Issue of Equivalent Shares and PDMR Notification.


    09 June 2025 23:10:25
  • Source: Sharecast
RNS Number : 9000L
Capai PLC
09 June 2025
 

THIS ANNOUNCEMENT ("ANNOUNCEMENT") AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, ITS STATES, TERRITORIES AND POSSESSIONS, AUSTRALIA, CANADA, JAPAN, SINGAPORE, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE PROHIBITED BY ANY APPLICABLE LAW.

9 June 2025

capAI plc
("capAI" or the "Company")

Allotment and Issue of Equivalent Shares and PDMR Notification

capAI plc (LSE: CPAI) announces that, further to its announcement on 29 May 2025 (RNS Number : 5031K) of its entry into the Stock Loan Agreement with Richard Andrew Edwards, a Director designated as Executive Chairman, it has today allotted and issued 400,000,000 Equivalent Shares to Mr Edwards in satisfaction of the Company's obligations to deliver such new Ordinary Shares under the Stock Loan Agreement.

The Equivalent Shares have been issued and allotted to Mr. Edwards under an exemption from the requirement to issue a prospectus. The Equivalent Shares rank pari passu with the existing Ordinary Shares and, have today been admitted to the equity shares (transition) category of the Official List of the FCA and to trading on the main market for listed securities of London Stock Exchange plc ("Admission").

Following Admission, the Company has 3,631,830,636 Ordinary Shares in issue, none of which are held in treasury. Therefore, the total number of voting rights in the Company are 3,631,830,636.

The above figure of 3,631,830,636 may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

As previously announced, the Company expects to publish its interim results for the period to 31 March 2025 on 30 June 2025 and therefore the Company has been in a closed period (for the purposes of Regulation 2014/596/EU, which is part of the domestic law of the United Kingdom of Great Britain and Northern Ireland pursuant to the Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310) ("UK MAR")) since 31 May 2025. The Company notes that all actions as outlined in the circular published by the Company and posted to Shareholders on 2 May 2025 (the "Circular") and the transactions envisaged by the Stock Loan Agreement on the dates specified, including the allotment and issue of the Equivalent Shares to Richard Edwards, would be compliant with UK MAR as the only actions within the closed period would be the implementation of actions resulting from irrevocable decisions made by the Board prior to the commencement of the closed period (for the purposes of UK MAR).

Capitalised terms in this Announcement have the meaning ascribed to them in the Definitions section of the Circular, unless otherwise defined in this Announcement.

 

For further information, please contact:

Company:
capAI plc hello@capaiplc.com

Broker Enquiries:
Peterhouse Capital Limited Tel: +44 (0) 207 469 0930



 

The information set out below is provided in accordance with the requirements of Article 19(3) of UK MAR.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Richard Edwards

2

Reason for Notification

a)

Position/status

Executive Director, PDMR

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

capAI plc

b)

LEI

213800IVPZ932NP24O44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares


Identification code

GB00BMWC6Q55

b)

Nature of the transaction

Issue of new ordinary shares (Equivalent Shares) pursuant to the Stock Loan Agreement dated 28 May 2025

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

400,000,000

d)

Aggregated information



- Aggregated volume

400,000,000


- Price

N/A

e)

Date of the transaction

9 June 2025

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEKZGGVGNGGKZM

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.